Utility Menu French

National Association of Pharmacy Regulatory Authorities

Provinces French

Main navigation French


Recherchez dans la base de données des Annexes nationales de médicaments

Commencez votre recherche en utilisant le nom générique du produit :

Recherche par annexe
Réinitialiser

ATTENTION : Tous les résultats de la recherche seront tirés du « National Drug Schedules » du site Web en anglais.

Nom du médicament (en anglais) Commentaire Annexe Date
Gabapentin or its salts or derivativesPDL I DEC / 13
Galantamine or its salts or derivativesPDL I DEC / 13
Galcanezumab PDL I OCT / 19
Gallamine triethiodidePDL I DEC / 13
Gallium or its saltsPDL I DEC / 13
GalsulfasePDL I DEC / 13
Gamithromuycin PDL I DEC / 13
Ganciclovir or its saltsPDL I DEC / 13
Ganirelix or its salts or derivativesPDL

Including but not limited to ganirelix acetate. 

I DEC / 13
Gatifloxacin or its salts or derivativesPDL I DEC / 13
GefitinibPDL I DEC / 13
Gemcitabine or its saltsPDL I DEC / 13
Gemfibrozil or its saltsPDL I DEC / 13
Gemifloxacin or its saltsPDL I DEC / 13
Gemtuzumab ozogamicin PDL I FEB / 20
Gentamicin or its salts or derivativesPDL

Including but not limited to netilmicin.

I DEC / 13
Gentian Violet II DEC / 01
Gilteritinib or its saltsPDL I FEB / 20
Glasdegib or its saltsPDL I JUL / 20
Glatiramer or its saltsPDL I DEC / 13
GlecaprevirPDL I SEP / 17
GliclazidePDL I DEC / 13
GlimepiridePDL I DEC / 13
GlipizidePDL I DEC / 13
Glucagon II SEP / 98
GlutethimideC1 I SEP / 98
Glyburide or its salts or derivativesPDL I DEC / 13
Glyceroargentinate III SEP / 98
Glycopyrrolate or its salts

except glycopyrronium bromide, including but not limited to glycopyrrolate, when used orally or for inhalation

II DEC / 17
Glycopyrronium bromidePDL

Including but not limited to glycopyrrolate, when used orally or for inhalation.

I DEC / 17
Gold or its salts or derivativesPDL

Including but not limited to aurothioglucose, auranofin and sodium aurothiomalate, when sold for administration by injection.

I DEC / 13
GolimumabPDL I DEC / 13
Gonadorelin or its saltsPDL I DEC / 13
Gonadotropin releasing factor or its analoguesPDL

For veterinary use.

I DEC / 13
Gonadotropin, chorionic (human)PDL I DEC / 13
Gonadotropins, serum (human)PDL I DEC / 13
Goserelin or its saltsPDL I DEC / 13
Gramicidin and its salts for topical use U
Gramicidin and its salts and derivatives for ophthalmic use III JUN / 06
Granisetron or its saltsPDL I DEC / 13
Grapiprant or its saltsPDL

For veterinary use

I FEB / 19
GrazoprevirPDL I AUG / 16
Grepafloxacin or its salts or derivativesPDL I DEC / 13
Griseofulvin or its salts or derivativesPDL

For human use.

I DEC / 13
Guaifenesin U
Guanethidine or its saltsPDL I DEC / 13
Guanfacine or its salts or derivativesPDL I DEC / 13
GuselkumabPDL I MAR / 18

48 résultats


Footnotes

  • C - Drug is listed in the Schedule to Part G of the Food and Drug Regulations under the Controlled Drugs and Substances Act
    N - Drug is listed in the Narcotic Control Regulations under the Controlled Drugs and Substances Act
    NR - Drug has not been reviewed by the NDSAC
    PDL - Drug is listed in the Health Canada Prescription Drug List
    TS - Drug is listed in the Benzodiazepines and Other Targeted Substances Regulations under the Controlled Drugs and Substances Act
    CR - Drug has been recommended for addition to the Controlled Drugs and Substances Act